MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q3 2024

SEC EDGAR SourceSEC Filings

Top Holdings95 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.9M$1.3B8.0%$228.73+85.39%
23 qtrssince 2019-Q1
Increased
63

APPLE INC

5M$1.2B7.3%$147.04+57.15%
23 qtrssince 2019-Q1
Increased
67

ALPHABET INC-CL A

4.9M$814.3M5.1%$100.48+62.35%
23 qtrssince 2019-Q1
Decreased
0

META PLATFORMS INC-CLASS A

1.2M$678.8M4.3%$273.15+106.89%
18 qtrssince 2020-Q2
Decreased
0

NVIDIA CORP

5.5M$673M4.2%$115.80+4.80%
23 qtrssince 2019-Q1
Increased
71

APPLIED MATERIALS INC

2.6M$532.5M3.4%$122.44+62.60%
15 qtrssince 2021-Q1
Decreased
0

AMAZON.COM INC

2.9M$531.3M3.3%$122.92+52.92%
23 qtrssince 2019-Q1
Decreased
0
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

28.8M$519.7M3.3%$9.50+83.77%
20 qtrssince 2019-Q4
Unchanged
0
FLINFLIN
ETF

FRANKLIN TEMPLETON ETF TR

10.4M$436.2M2.7%$33.17+25.86%
6 qtrssince 2023-Q2
Increased
62

MASTERCARD INC - A

850,269$419.9M2.6%$341.13+43.48%
15 qtrssince 2021-Q1
Decreased
0

WALMART INC

4.8M$387.4M2.4%$53.71+46.81%
23 qtrssince 2019-Q1
Decreased
0

JPMORGAN CHASE & CO

1.6M$332.6M2.1%$146.85+38.89%
5 qtrssince 2023-Q3
Decreased
0
XLUXLU
ETF

UTILITIES SELECT SECTOR SPDR

4.1M$327.5M2.1%$37.79+2.60%
7 qtrssince 2023-Q1
Increased
86

HOME DEPOT INC

779,180$315.7M2.0%$301.26+28.71%
23 qtrssince 2019-Q1
Increased
66

UNITEDHEALTH GROUP INC

539,721$315.6M2.0%$472.73+19.67%
8 qtrssince 2022-Q4
Decreased
0

OTIS WORLDWIDE CORP

3M$310.9M2.0%$68.22+46.64%
18 qtrssince 2020-Q2
Increased
58

ABBVIE INC

1.6M$307.4M1.9%$117.44+57.46%
18 qtrssince 2020-Q2
Increased
49
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

1.6M$283.4M1.8%$94.09+86.04%
8 qtrssince 2022-Q4
Increased
52
NICENICE
ADR

NICE LTD - SPON ADR

1.6M$281.9M1.8%$182.53-6.08%
3 qtrssince 2024-Q1
Increased
69

NOVA LTD

1.3M$269M1.7%$49.23+325.78%
23 qtrssince 2019-Q1
Unchanged
0
$15.9B
AUM
95
Positions
Q3 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
+12%Q2'23$10.8B+2%Q3'23$11B+8%Q4'23$11.9B+12%Q1'24$13.3B+10%Q2'24$14.7B+8%Q3'24$15.9B
Activity profile
$ moved · Q3'24
New18%Increased42%Decreased23%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q3%1-4Q15%1-2Y38%2Y+44%

MENORA MIVTACHIM HOLDINGS LTD. manages $15.9B across 95 positions as of Q3 2024. Top holdings: MSFT (8.0%), AAPL (7.3%), GOOGL (5.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2024 Summary

Active quarter - 9 new positions, 10 exits, 35 increased. Top move: XLU (INCREASED, conviction 86). Portfolio: $15.9B across 95 positions.

Top holdings by portfolio weight

Total AUM$16B
MSFT7.98%
AAPL7.35%
GOOGL5.13%
META4.28%
NVDA4.24%
AMAT3.36%
AMZN3.35%
TEVA3.27%
FLIN2.75%
MA2.65%
Other2.44%

Portfolio allocation by GICS sector

Sectors11
Technology33.11%
Healthcare11.84%
Unknown11.73%
Financial Services9.79%
Communication Services9.56%
Consumer Cyclical8.64%
Industrials4.16%
Consumer Defensive3.83%
Basic Materials2.69%
Real Estate2.10%
Other2.54%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used